Xiao-Ran Li, Han-Lin Liu, Li Wang, Jian-Wei Yang, Kang-Yu Wang, Si-Yu Chen, Li Yang
{"title":"Association between life's crucial 9 and kidney stones: a population-based study.","authors":"Xiao-Ran Li, Han-Lin Liu, Li Wang, Jian-Wei Yang, Kang-Yu Wang, Si-Yu Chen, Li Yang","doi":"10.3389/fmed.2025.1558628","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study examined the association between the Life's Crucial 9 (LC9) score and kidney stone prevalence in U.S. adults.</p><p><strong>Methods: </strong>Using data from the National Health and Nutrition Examination Survey (NHANES) spanning 2007 to 2014, this cross-sectional analysis focused on adult participants with kidney stone onset or recurrence. LC9 scores were divided into four quartiles for analysis. Weighted multivariable logistic regression, restricted cubic spline (RCS) modeling, threshold effect analysis, and subgroup analyses were employed to evaluate the relationship between LC9 scores and kidney stone prevalence.</p><p><strong>Results: </strong>The study included 24,669 participants with an average age of 46.05 ± 0.34 years and a mean LC9 score of 73.76 ± 0.25. The overall prevalence of kidney stones was 8.45%, while the average recurrence rate stood at 2.96%. Importantly, for each one-point increase in the LC9 score, the incidence of kidney stones dropped by 1.2% (95% CI: 0.979 to 0.997, <i>p</i> = 0.014). Compared to the lowest quartile (Q1), the Q4 group exhibited a 0.305-fold higher recurrence rate (95% CI: 0.159 to 0.586, <i>p</i> < 0.001). Interaction analysis showed that race and gout significantly influenced the relationship between the LC9 score and kidney stone risk. Additionally, curve fitting and threshold effect analysis demonstrated a nonlinear association between LC9 scores and kidney stone recurrence, with a breakpoint identified at 72.777.</p><p><strong>Conclusion: </strong>An elevated LC9 score correlates with a lower risk of both kidney stone formation and recurrence. Maintaining an optimal LC9 score could be an effective approach for preventing kidney stones.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"12 ","pages":"1558628"},"PeriodicalIF":3.1000,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11922861/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2025.1558628","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: This study examined the association between the Life's Crucial 9 (LC9) score and kidney stone prevalence in U.S. adults.
Methods: Using data from the National Health and Nutrition Examination Survey (NHANES) spanning 2007 to 2014, this cross-sectional analysis focused on adult participants with kidney stone onset or recurrence. LC9 scores were divided into four quartiles for analysis. Weighted multivariable logistic regression, restricted cubic spline (RCS) modeling, threshold effect analysis, and subgroup analyses were employed to evaluate the relationship between LC9 scores and kidney stone prevalence.
Results: The study included 24,669 participants with an average age of 46.05 ± 0.34 years and a mean LC9 score of 73.76 ± 0.25. The overall prevalence of kidney stones was 8.45%, while the average recurrence rate stood at 2.96%. Importantly, for each one-point increase in the LC9 score, the incidence of kidney stones dropped by 1.2% (95% CI: 0.979 to 0.997, p = 0.014). Compared to the lowest quartile (Q1), the Q4 group exhibited a 0.305-fold higher recurrence rate (95% CI: 0.159 to 0.586, p < 0.001). Interaction analysis showed that race and gout significantly influenced the relationship between the LC9 score and kidney stone risk. Additionally, curve fitting and threshold effect analysis demonstrated a nonlinear association between LC9 scores and kidney stone recurrence, with a breakpoint identified at 72.777.
Conclusion: An elevated LC9 score correlates with a lower risk of both kidney stone formation and recurrence. Maintaining an optimal LC9 score could be an effective approach for preventing kidney stones.
期刊介绍:
Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate
- the use of patient-reported outcomes under real world conditions
- the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines
- the scientific bases for guidelines and decisions from regulatory authorities
- access to medicinal products and medical devices worldwide
- addressing the grand health challenges around the world